title: Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
abstract: BACKGROUND
  Pregnant women acutely infected with human parvovirus B19 (B19) may transmit the virus to the developing fetus. The mechanism whereby the virus interacts with the placenta is unknown. It is known that globoside receptor is required for successful infection of the target cells, which are the highly undifferentiated, actively dividing colony and burst-form units of the erythroid series. Globoside is present on trophoblast cells which have intimate contact with maternal blood, and may therefore serve as a potential route for B19 transmission into the fetal compartment.
  
  
  OBJECTIVE
  The purpose of this study was to determine whether B19 VP2 capsids could bind to villous trophoblast cells in vitro and whether globoside was involved.
  
  
  METHODS
  Binding of B19 VP2 empty capsid to first-trimester villous trophoblast cells was assessed by multiple approaches, including ICC using either biotinylated B19 VP2 empty capsid or unlabeled B19 VP2 empty capsid. Quantification of viral binding involved I125-labeled B19 VP2 empty capsid. Competition studies included excess unlabeled empty capsids or pretreatment with globoside-specific IgM antibody.
  
  
  RESULTS
  Linear binding of B19 VP2 capsid to purified villous trophoblast cells in vitro was clearly demonstrated (R2= 0.9524). Competition studies revealed specificity of I125-labeled B19 VP2 capsid binding to villous trophoblast cells when pretreatment with either 60-fold excess unlabeled B19 capsid or globoside-specific IgM antibody took place. The results illustrated B19's ability to bind in a specific manner to globoside-containing villous trophoblast cells.
  
  
  CONCLUSIONS
  We speculate that the globoside present on trophoblast cells may play a role in viral binding in vivo, which may facilitate B19 transmission across the maternal-fetal interface.
authors.affiliation: University of Pittsburgh, Department of Pathology, Pittsburgh, PA, USA.
authors.forename: Carole C
authors.initials: CC
authors.lastname: Wegner
authors.forename: Jeanne A
authors.initials: JA
authors.lastname: Jordan
mesh_terms: D001667:Binding, Competitive; D019921:Biotinylation; D002213:Capsid / Q000378:metabolism*; D005260:Female; D005915:Globosides / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007075:Immunoglobulin M / Q000494:pharmacology; D007457:Iodine Radioisotopes; D016732:Parvovirus B19, Human / Q000378:metabolism*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D014327:Trophoblasts / Q000737:chemistry / Q000821:virology*
chemical_list: D005915:Globosides; D007075:Immunoglobulin M; D007457:Iodine Radioisotopes
references.citation: Placenta. 1999 Jan;20(1):103-8
references.pmid: 9950151
references.citation: Semin Hematol. 1965 Apr;2:167-203
references.pmid: 14264614
references.citation: Br J Haematol. 1986 May;63(1):35-46
references.pmid: 2423110
references.citation: J Virol. 1986 Jun;58(3):921-36
references.pmid: 3701931
references.citation: Endocrinology. 1986 Apr;118(4):1567-82
references.pmid: 3512258
references.citation: Science. 1984 Dec 7;226(4679):1161-5
references.pmid: 6095448
references.citation: Nature. 1983 Mar 31-Apr 6;302(5907):426-9
references.pmid: 6835376
references.citation: Lancet. 1975 Jan 11;1(7898):72-3
references.pmid: 46024
references.citation: Placenta. 2002 Aug;23(7):547-53
references.pmid: 12175970
references.citation: J Gen Virol. 2002 Feb;83(Pt 2):273-81
references.pmid: 11807219
references.citation: J Virol. 2001 Aug;75(16):7555-63
references.pmid: 11462027
references.citation: J Virol. 2001 May;75(9):4110-6
references.pmid: 11287560
references.citation: Placenta. 2001 Jan;22(1):44-8
references.pmid: 11162351
references.citation: Biochem J. 1963 Oct;89:114-23
references.pmid: 14097352
references.citation: J Infect. 1999 Jul;39(1):68-76
references.pmid: 10468132
references.citation: Fetal Diagn Ther. 2001 Jan-Feb;16(1):26-31
references.pmid: 11125248
references.citation: Curr Opin Cell Biol. 1998 Oct;10(5):660-6
references.pmid: 9818178
references.citation: J Immunol Methods. 1989 May 12;119(2):259-68
references.pmid: 2470826
references.citation: J Virol. 1987 Aug;61(8):2395-406
references.pmid: 3599180
references.citation: N Engl J Med. 1987 Jan 22;316(4):183-6
references.pmid: 3025725
references.citation: N Engl J Med. 1994 Apr 28;330(17):1192-6
references.pmid: 8139629
references.citation: J Anat. 1994 Apr;184 ( Pt 2):297-308
references.pmid: 8014121
references.citation: Virology. 1994 Aug 15;203(1):106-15
references.pmid: 8030266
references.citation: J Infect Dis. 1995 Nov;172(5):1198-205
references.pmid: 7594654
references.citation: Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):37-42
references.pmid: 8572031
references.citation: Hum Reprod. 1997 Feb;12(2):379-82
references.pmid: 9070730
references.citation: J Cell Biol. 1997 Sep 22;138(6):1379-94
references.pmid: 9298992
references.citation: J Virol. 1998 Apr;72(4):3018-28
references.pmid: 9525624
references.citation: Blood. 1990 Feb 1;75(3):603-10
references.pmid: 2404522
references.citation: Br J Haematol. 1991 Sep;79(1):6-13
references.pmid: 1654995
references.citation: Blood. 1992 Jan 1;79(1):18-24
references.pmid: 1728307
references.citation: Semin Diagn Pathol. 1992 Feb;9(1):4-12
references.pmid: 1561488
references.citation: Virology. 1992 Aug;189(2):456-61
references.pmid: 1641977
references.citation: J Gen Virol. 1992 Aug;73 ( Pt 8):2147-9
references.pmid: 1645153
references.citation: J Pathol. 1993 Feb;169(2):213-20
references.pmid: 8445486
references.citation: Science. 1993 Oct 1;262(5130):114-7
references.pmid: 8211117
references.citation: J Virol. 1986 Nov;60(2):548-57
references.pmid: 3021988